StreetAlpha.app
Home › Stocks › ICLR

Icon PLC (ICLR)

Healthcare
$195.02
▲ +1.89%
LAST CLOSE · NOV 17

ICON provides outsourced clinical development and commercialization services to pharmaceutical, biotech and medical device companies. It last closed at $195.02 on Nov 17, up 1.89% on the day. ICLR last reported earnings on Tue, Oct 27, 2026. The average 12-month price target from 7 analysts is $239.71 (+22.9% from the last close), with a high of $268.00 and a low of $215.00. Analyst consensus is Buy, based on the latest ratings from 7 firms (4 buy, 3 hold, 0 sell). In the past 30 days there were 4 dark pool prints totaling $5.0M, the largest $1.8M.

AI Auto Pilots
Is ICLR in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$8.2B
+1.8% vs a year ago
Net income
$448.7M
+55.9% vs a year ago
Free cash flow
$857.1M
10.4% margin
Operating margin
8.7%
$718.3M operating income
Balance sheet
Cash & equivalents
$809.0M
At Sep 30
Debt
$3.4B
At Sep 30
Shareholder equity
$9.1B
Buybacks
$400.0M
Last 12 months
Employees40,100 (Dec 31, 2025)
ExchangeNasdaq
Financials history
FY2021: $5.5B$5.5BFY2021FY2022: $7.7B$7.7BFY2022FY2023: $8.1B$8.1BFY2023FY2024: $8.2B$8.2BFY2024FY2025: $8.3B$8.3BFY2025

From ICLR's SEC filings, latest 20-F for the period ending Sep 30, 2026 (filed May 27). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Last report
Oct 27
2026 · After the close (AMC)
Reported EPS
$2.46
vs $2.40 est. · beat
Year-ago EPS
$3.31
Same quarter last year
Options-implied move
±10.2%
Priced in before that report
Analyst consensus
Buy
Based on 7 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
7firms
4 Buy3 Hold0 Sell
Each firm's latest rating on ICLR in the past 90 days
Average 12-month target
$239.71
▲ 22.9% upside

Based on 7 analysts who set a price target on ICLR in the past 90 days. The average target is $239.71, with a high of $268.00 and a low of $215.00, compared with the last close of $195.02.

Low $215.00Avg $239.71High $268.00
Blue marker: last close $195.02
Highest target$268.00
Average target$239.71
Lowest target$215.00
Latest rating changes
RBC CapitalTarget raised
Oct 29Buy$185 → $226
CitigroupTarget raised
Oct 29Hold$175 → $215
TD CowenTarget raised
Oct 29Buy$197 → $254
UBSTarget raised
Oct 29Hold$195 → $236
BarclaysTarget raised
Oct 29Hold$175 → $230
DateFirmActionRatingPrice target
Oct 29RBC CapitalTarget raisedBuy$185 → $226
Oct 29CitigroupTarget raisedHold$175 → $215
Oct 29TD CowenTarget raisedBuy$197 → $254
Oct 29UBSTarget raisedHold$195 → $236
Oct 29BarclaysTarget raisedHold$175 → $230
Loading…

Technical Analysis

ICLR · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 25% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 53). The nearest support is the Pivot at $194.29, and the nearest resistance the Pivot R1 at $198.03.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 4.2%/day
Key levels
$219.0452 week high+12.3%
$210.52Swing high (Nov 9)+7.9%
$198.7820 day average+1.9%
$198.03Pivot R1+1.5%
$195.02Last close
$194.29Pivot−0.4%
$191.29Pivot S1−1.9%
$180.2850 day average−7.6%
$174.02100 day average−10.8%
$162.83Swing low (Jul 14)−16.5%
$146.83200 day average−24.7%
$66.5752 week low−65.9%
Indicators
RSI (14)52.77Middle of its rangeNeutral
MACD5.16Below its signal lineBearish
Stochastic21.7Middle of its rangeNeutral
ADX (14)35.2Trending up
Williams %R-78.8Oversold below −80, overbought above −20Neutral
CCI (20)-31.5Oversold below −100, overbought above 100Neutral
Rate of change−4.3%Change over 10 sessionsBearish
ATR (14)$8.15Typical daily range, 4.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for ICLR

What happened before

See how ICLR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ICLR usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ICLR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ICLR in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
4
Notional
$5.0M
Largest print
$1.8M
Loading…

ICLR Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●198 buying vs 193 selling
  • ▼Shares held by funds -5.2%
  • ●Funds holding -4
  • ▲Superinvestors: 3 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding422426−0.9%
In funds' top 101619−15.8%
Held by funds–––
New / increased45 / 15383 / 147−13.9%
Reduced / sold out148 / 45141 / 80−12.7%
Put/call ratio1.800.71+155.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ICLR institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ICLR is in one of them and how their past ICLR trades turned out.

ICLR in the AI portfolios
Loading…

ICLR News & Analysis

All StreetAlpha news →
ICLR in the news

ICLR Congress Trades

All congress trades →
Trades, 12 months
4
Buys
0
0%
Sells
4
100%
People
3
Last filed Sep 1
Who traded ICLR · since 2019
Latest 5 filings of 12
Kevin HernSell (partial)
$15K – $50KTraded Aug 14, 2026Filed Sep 1, 2026
$1K – $15KTraded Feb 19, 2026Filed May 14, 2026
$100K – $250KTraded Mar 5, 2026Filed Apr 3, 2026
$1K – $15KTraded Feb 12, 2026Filed Mar 12, 2026
$15K – $50KTraded Jun 9, 2025Filed Sep 6, 2025
PersonTypeAmountTradedFiledDelay
Kevin HernR · OKSell (partial)$15K – $50KAug 14, 2026Sep 1, 202618 d
Donald J TrumpExecutive branchSell$1K – $15KFeb 19, 2026May 14, 202684 d
Kevin HernR · OKSell$100K – $250KMar 5, 2026Apr 3, 202629 d
Julia LetlowR · LASell$1K – $15KFeb 12, 2026Mar 12, 202628 d
Stephen I MiranExecutive branchSell$15K – $50KJun 9, 2025Sep 6, 202589 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Icon

ICON is an outsourced development and commercialization services provider based in Dublin, Ireland. It serves pharmaceutical, biotechnology, medical device, and government and public health organizations. Its services cover clinical development strategy, trial design, full study execution and commercialization of treatments. The company works across all phases of clinical development, from Phase I to Phase IV studies. Offerings also include clinical trial management, consulting, contract staffing, data solutions and laboratory services.

Headquarters
Dublin 18, Ireland